VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression.
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. Clin Cancer Res. 2017 Jul 15; 23(14):3711-3720.
View in:
PubMed
subject areas
Animals
B7-H1 Antigen
Breast Neoplasms
Cell Line, Tumor
Female
Gene Expression Regulation, Neoplastic
Humans
Lymphocytes, Tumor-Infiltrating
Mice
Poly (ADP-Ribose) Polymerase-1
Poly(ADP-ribose) Polymerase Inhibitors
Programmed Cell Death 1 Receptor
Tumor Microenvironment
Xenograft Model Antitumor Assays
authors with profiles
MIEN-CHIE HUNG
WEIYA XIA
BANU K ARUN
CHAO-KAI CHOU
JENNIFER LITTON
HIROHITO YAMAGUCHI
SEUNG-OE LIM